Stay updated on Eribulin + Pembrolizumab in Soft Tissue Sarcomas Clinical Trial

Sign up to get notified when there's something new on the Eribulin + Pembrolizumab in Soft Tissue Sarcomas Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Eribulin + Pembrolizumab in Soft Tissue Sarcomas Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The page footer has an updated software/UI revision label from v3.5.2 to v3.5.3.
    Difference
    0.1%
    Check dated 2026-04-26T15:47:44.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    Revision label updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-19T14:30:38.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    32 days ago
    Change Detected
    Summary
    Added the MeSH term Malignant fibrous histiocytoma to the study's indexing terms.
    Difference
    0.1%
    Check dated 2026-03-29T04:28:10.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    Revision: v3.5.0 is now displayed, replacing the previous Revision: v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-21T20:44:30.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    Revision: v3.4.3 added; Revision: v3.4.2 removed.
    Difference
    0.1%
    Check dated 2026-03-07T08:47:01.000Z thumbnail image
  7. Check
    75 days ago
    Change Detected
    Summary
    Revision updated from v3.4.1 to v3.4.2; no study content or eligibility details were altered. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-13T17:35:35.000Z thumbnail image

Stay in the know with updates to Eribulin + Pembrolizumab in Soft Tissue Sarcomas Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Eribulin + Pembrolizumab in Soft Tissue Sarcomas Clinical Trial page.